Research Highlight | Published:

PREVENTION

Aspirin for primary prevention of CVD: a matter of balance

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original articles

    1. The ASCEND Study Collaborative Group. Effects of aspirin for primary prevention in persons with diabetes mellitus. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1804988 (2018)

    2. Gaziano, J. M. et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet https://doi.org/10.1016/S0140-6736(18)31924-X (2018)

    Download references

    Author information

    Correspondence to Irene Fernández-Ruiz.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark